DRZID
ELV icon

DePrince Race & Zollo Inc (DRZ)’s Elevance Health ELV Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1M Sell
62,342
-50,018
-45% -$18.5M 0.4% 105
2026
Q1 		$32.9M Sell
112,360
-240
-0.2% -$78.9K 0.62% 72
2025
Q4 		$39.5M Buy
112,600
+48,580
+76% +$16.4M 0.76% 53
2025
Q3 		$20.7M Buy
+64,020
New +$19.9M 0.42% 105

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s ELV Position: Q2 2026 in Review

DePrince Race & Zollo Inc (DRZ) reduced its Elevance Health (ELV) stake by 45% in Q2 2026, selling an estimated $18.5M and leaving 62,342 shares worth $24.1M. The position accounts for 0.4% of the portfolio, ranked #105.

DePrince Race & Zollo Inc (DRZ) first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. The position peaked at $39.5M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • DePrince Race & Zollo Inc (DRZ) held 62,342 shares of Elevance Health worth $24.1M as of Q2 2026.
  • DePrince Race & Zollo Inc (DRZ) sold 50,018 Elevance Health shares in Q2 2026, an estimated $18.5M.
  • Elevance Health made up 0.4% of DePrince Race & Zollo Inc (DRZ)'s portfolio in Q2 2026, its #105 holding.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • DePrince Race & Zollo Inc (DRZ)'s Elevance Health position peaked at $39.5M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q2 2026, filed 20 Aug 2026.